Skip to main content
DaehanPharmaceutical logo

DaehanPharmaceutical — Investor Relations & Filings

Ticker · 023910 ISIN · KR7023910003 KO Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2026-06-12 Director's Dealing
Country KR South Korea
Listing KO 023910

About DaehanPharmaceutical

https://www.dhnp.co.kr/

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” which details the officer’s shareholdings and transaction history on specific dates. This matches an insider trading report by a company director/executive. Therefore, it falls under Director’s Dealing (insider trades).
2026-06-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” and details share ownership and daily trading changes by a company executive (이윤우). It provides the insider’s personal transactions, holdings before/after each trade, and the dates/prices. This matches the definition of a Director’s Dealing report (DIRS), which covers personal share transactions by company directors and executives.
2026-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a Korean regulatory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Report on Officers and Major Shareholders’ Holdings of Specific Securities). It details an executive’s personal shareholdings, acquisition dates (장내매수), changes in number of shares, and ownership percentages. This matches an insider trading or director share transactions report. According to the taxonomy, this is a Director’s Dealing (DIRS) filing.
2026-05-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a detailed report titled “주식등의 대량보유상황보고서(일반)” (Large Shareholding Status Report), including tables of share counts, ownership percentages, related persons, and transaction histories under the Capital Markets Act. This corresponds to a Major Shareholding Notification, wherein significant share ownership changes and threshold crossings are disclosed. Therefore, it matches Filing Definition #20: Major Shareholding Notification (Code: MRQ).
2026-05-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a mandatory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Report of Officers and Major Shareholders on Specific Securities Ownership), detailing the holdings and transaction history (purchase dates, share counts, ratios) by an executive (Lee Yoon Woo). This matches an insider share transaction report. Therefore, it is a Director’s Dealing filing.
2026-05-22 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is titled “분기보고서 (제 63기) 2026년 01월 01일~2026년 03월 31일,” which translates to a quarterly report for Q1 2026. It includes detailed financial statements, management’s analysis (MDA), auditor’s opinion, segment data, risk management, and other substantive financial disclosures. It is the full interim/quarterly report, not merely an announcement or summary. Therefore, it is classified as an Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.